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mucosa; barrier function; adenosine 3Ј,5Ј-cyclic monophosphate; G protein; short-circuit current 16 ,16-DIMETHYL-PGE 2 (PGE 2 ) stimulates recovery of barrier function in porcine ischemia-injured ileal mucosa, but the PGE 2 receptor interactions involved in this model are unknown (3) (4) (5) . PGE 2 may interact with at least four cell surface prostaglandin type E receptors (EP 1 , EP 2 , EP 3 , and EP 4 ), which trigger a variety of intracellular responses depending on which G protein they are coupled to (12, 17) . For example, PGE 2 stimulates production of cAMP via EP 2 and EP 4 receptors linked to G s protein (6, 21) but inhibits production of cAMP via EP 3 receptors coupled to G i protein (8, 19, 24) . Furthermore, PGE 2 may increase intracellular Ca 2ϩ via EP 1 (29) and EP 3 (16) receptors through G q protein-phospholipase C interactions. From previous studies (5), we know that porcine mucosal tissue cAMP is elevated in response to PGE 2 and that the phosphodiesterase inhibitor theophylline heightens the effect of PGE 2 on recovery of transmucosal resistance (R). Although this data implicates a role for EP 2 or EP 4 receptors coupled to G s protein, we do not know whether EP receptors that increase intracellular Ca 2ϩ are also involved. Studies indicate a critical role for the EP 3 receptor in duodenal bicarbonate secretion in mice (26, 27) and for PGE 2 -stimulated cytoprotection of gastric parietal cells (22) . Work from other laboratories indicates that EP 1 , EP 3 , and EP 4 mRNA have all been detected in the mucosa or submucosa of the mouse (15) and rat (9) , whereas EP 2 receptor mRNA was not detected in the gastrointestinal tract of rodents. However, EP 2 receptors have been detected in normal and inflamed human colonic mucosal epithelium (25) .
In the present study, we sought to determine the nature of PGE 2 -EP receptor interactions involved in PGE 2 -stimulated recovery of R through a series of experiments using receptor-specific agonists and antagonists. Our data indicate that the response of ischemia-injured porcine ileal mucosa to PGE 2 involves an intriguing cross talk mechanism between EP receptors linked to the generation of cAMP and intracellular Ca 2ϩ , respectively.
MATERIALS AND METHODS
Experimental animal surgeries. All studies were approved by the North Carolina State University Institutional Animal Care and Use Committee. Six-to eight-wk-old Yorkshire crossbred pigs of either sex were housed singularly and maintained on a commercial pelleted feed. Pigs were held off feed for 24 h before experimental surgery. General anesthesia was induced with xylazine (1.5 mg/kg im), ketamine (11 mg/kg im), and pentobarbital sodium (15 mg/kg iv) and maintained with intermittent infusion of pentobarbital sodium (6-8 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ). Pigs were placed on a heating pad and ventilated with 100% O 2 via a tracheotomy by using a timecycled ventilator. The jugular vein and carotid artery were cannulated, and blood gas analysis was performed to confirm normal pH and partial pressures of CO 2 and O2. Lactated Ringer solution was administered intravenously at a maintenance rate of 15 ml ⅐ kg Ϫ1 ⅐ h
Ϫ1
. Blood pressure was continuously monitored via a transducer connected to the carotid artery. The ileum was approached via a ventral midline incision. Ileal segments were delineated by ligating the intestinal lumen at 10-cm intervals and were subjected to ischemia by clamping the local mesenteric blood supply for 45 min.
Ussing chamber studies. After the ischemic period, the mucosa was stripped from the seromuscular layer in oxygenated (95% O 2-5% CO2) Ringer solution and mounted in 3.14-cm 2 -aperture Ussing chambers, as described previously (1) . Tissues were bathed on the serosal and mucosal sides with 10 ml Ringer solution. The serosal bathing solution contained 10 mM glucose and was osmotically balanced on the mucosal side with 10 mM mannitol. Bathing solutions were oxygenated (95% O 2-5% CO2) and circulated in water-jacketed reservoirs. The spontaneous potential difference (PD) was measured using Ringer-agar bridges connected to calomel electrodes, and PD was short-circuited through Ag-AgCl electrodes using a voltage clamp that corrected for fluid resistance. R (in ⍀ ⅐ cm 2 ) was calculated from the spontaneous PD and short-circuit current (I sc). If the spontaneous PD was between Ϫ1 and 1 mV, tissues were current clamped at Ϯ100 A for 5 s and the PD was recorded. I sc and PD were recorded every 15 min for 4 h.
Experimental treatments. Tissues were bathed in Ringer containing 5 M indomethacin to prevent PG production while mucosa was stripped from the seromuscular tissues, and indomethacin was added to the serosal and mucosal bathing solutions in the same concentration before tissues were mounted on Ussing chambers. Other treatments that were added before baseline electrical measurements were SC-19220 (Cayman Chemical), AH-6809 (Biomol), pertussis toxin, or TTX (Sigma Chemical, St. Louis, MO). Baseline electrical readings were taken for 30 min, after which further treatments were added to the tissues depending on the study. Treatments added after the 30-min equilibration included PGE2, A-23187, thapsigargin (Sigma Chemical), sulprostone, 11-deoxy-PGE1, misoprostol, or 11-deoxy-16,16-dimethyl-PGE2 (Cayman Chemical).
cAMP RIA. Tissues were removed from Ussing chambers once Isc peaked in response to receptor agonists and were immediately frozen in liquid N 2. Tissues were stored at Ϫ70°C before extraction and RIA. One part tissue (100 mg) was homogenized with nine parts 5% TCA. The homogenate was centrifuged at 2,500 g at 4°C for 15 min and extracted three times with 5 vol of water-saturated ether. Excess ether was discarded after each extraction, and the samples were evaporated to dryness. RIA for cAMP was performed using a commercial kit according to the manufacturer's instructions (Biomedical Technologies, Stoughton, MA).
Data analysis. Data are reported as means Ϯ SE. All data were analyzed using an ANOVA for repeated measures except when the peak response was analyzed using a standard one-way ANOVA or paired t-test (Sigmastat, Jandel Scientific, San Rafael, CA). Tukey's test was used to determine differences between treatments after ANOVA, and P Ͻ 0.05 was considered significant.
RESULTS
Ischemia-injured tissues bathed in indomethacin (5 M) and treated with the EP 1 , EP 2 , EP 3 , and EP 4 agonist PGE 2 (1 M) after a 30-min equilibration period showed marked elevations in R compared with tissues treated with indomethacin alone (Fig. 1A) . However, neither the EP 2 and EP 4 agonist deoxy-PGE 1 (1 M) nor the EP 1 and EP 3 agonist sulprostone (1 M) had any effect on R, whereas a combination of deoxy-PGE 1 and sulprostone stimulated synergistic elevations in R similar in magnitude to that of PGE 2 (Fig.  1A ). Because we have previously shown that recovery of R is preceded by increases in I sc (3, 5) , we also evaluated I sc data for the presence of similar trends (Fig. 1B) . Accordingly, there was no effect of either deoxy-PGE 1 or sulprostone on I sc , but a combination of the two agents triggered elevations in I sc similar in magnitude to that of PGE 2 .
Because we have previously demonstrated that elevations in R in response to PGE 2 were correlated with Fig. 1 . Electrical responses of ischemia-injured tissues treated with various prostanoid type E (EP) receptor agonists. A: serosal addition of the EP1, EP2, EP3, and EP4 receptor agonist 16,16-dimethyl-PGE2 (PGE2; 1 M) to ischemia-injured tissues after an initial 30-min equilibration period resulted in ϳ2-fold elevations in transmucosal resistance (R), whereas treatment of tissues with the EP2 and EP4 receptor agonist deoxy-PGE1 (1 M) or the EP1 and EP3 receptor agonist sulprostone (1 M) had no apparent effect. However, addition of deoxy-PGE1 and sulprostone stimulated synergistic elevations in R. B: elevations in R after treatment with PGE2 or deoxy-PGE1 ϩ sulprostone were preceded by elevations in short-circuit current (Isc). Values are means Ϯ SE; n ϭ 6. The significance of the synergism between deoxy-PGE1 and sulprostone was determined using 2-way ANOVA on repeated measures (P Ͻ 0.05).
elevations in tissue cAMP (5), we next measured cAMP levels in response to various prostanoids. Tissues were taken for measurement of cAMP immediately after peak I sc response. In ischemia-injured tissues treated with PGE 2 , cAMP was elevated approximately twofold compared with tissues treated with indomethacin alone (Fig. 2) . Although neither sulprostone nor deoxy-PGE 1 triggered elevations in cAMP above that of indomethacin-treated tissues, a combination of sulprostone and deoxy-PGE 1 elevated cAMP approximately twofold, similar to the effect of PGE 2 . These data suggested cross talk between EP receptors wherein stimulation of EP 2 Values are means Ϯ SE. Indomethacin was administered at 5 M, 16,16-dimethyl PGE2 at 1 M, SC-19220 at 100 M, AH-6809 at 100 M, pertussis toxin at 125 mg/ml, and TTX at 0.1 M. Isc, shortcircuit current; R, transmucosal resistance; EP1 receptor, prostanoid type E receptor 1. tissues to PGE 2 or deoxy-PGE 1 plus sulprostone, tissues were pretreated with the EP 1 receptor antagonists SC-19220 or AH-6809. However, these antagonists had no effect on either PGE 2 (Table 1) or sulprostone plus deoxy-PGE 1 -triggered elevations (data not shown) in R or I sc at doses of 1-100 M. This agreed with other studies (18) indicating that sulprostone has a preferential action on EP 3 receptors.
We next focused on which of the EP 3 receptor splice variants was involved in the response of tissues to PGE 2 . Because G o and G i proteins have an inhibitory action on neuronal Ca 2ϩ channels and adenylyl cyclase, respectively (10), it seemed unlikely that EP 3A would be responsible for the stimulatory action of prostanoids on R and I sc in ischemia-injured ileum. To further exclude a role for EP 3A receptors, ischemiainjured tissues were pretreated for up to 60 min with 125 mg/ml pertussis toxin (to which G o and G i proteins are sensitive) and subsequently treated with PGE 2 or sulprostone plus deoxy-PGE 1 . However, pertussis toxin had no effect on measurements of R and I sc (Table  1) . Because G o protein is largely expressed in neuronal tissue (10), we also pretreated tissues with TTX (0.1 M), but this neuronal inhibitor had no effect on subsequent treatment of ischemia-injured tissues with PGE 2 (Table 1) or sulprostone plus deoxy-PGE 1 (data not shown).
Of the remaining splice variants of EP 3 , EP 3D linked to G q protein, with associated elevations in intracellular Ca 2ϩ , was considered the most likely candidate for a cross talk response with EP 2 -or EP 4 -linked G s protein. Therefore, tissues were treated with deoxy-PGE 1 and the calcium ionophore A-23187 (0.1 M) to stimulate increases in Ca 2ϩ independent of receptor interactions. Treatment of tissues with A-23187 stimulated increases in R compared with tissues treated with indomethacin alone (Fig. 3A) . However, treatment of tissues with deoxy-PGE 1 and A-23187 triggered synergistic elevations in R, and evaluation of I sc revealed similar trends (Fig. 3B) . In addition, tissue cAMP measurements indicated that A-23187 in combination with deoxy-PGE 1 stimulated significant elevations in cAMP, whereas neither A-23187 nor deoxy-PGE 1 had any , and deoxy-PGE1. A: synergistic elevations in R in tissues treated with thapsigargin (0.1 M) and deoxy-PGE1 (1 M) were noted that were qualitatively similar to those of tissues treated with A-23187 and deoxy-PGE1, indicating that an increase in intracellular Ca 2ϩ is required for the full tissue response to E-type prostanoids. B: synergistic elevations in Isc were also noted in tissues treated with thapsigargin and deoxy-PGE1. Values are means Ϯ SE; n ϭ 6. The significance of the synergistic response between thapsigargin and deoxy-PGE1 was determined using 2-way ANOVA on repeated measures (P Ͻ 0.05). effect when given alone (Fig. 4) . Although these results were suggestive of a role for intracellular Ca 2ϩ in the cross talk response between EP receptors, A-23187 can also elevate phospholipid second messengers via stimulation of phospholipase C (13). Therefore, we next used thapsigargin, which has been shown to elevate intracellular Ca 2ϩ from intracellular and extracellular Ca 2ϩ sources without stimulating other second messenger signaling mechanisms (13) . Tissues were treated with combinations of thapsigargin (0.1 M) and deoxy-PGE 1 (1 M) that, similar to experiments with A-23187 and deoxy-PGE 1 , induced synergistic elevations in R and I sc (Fig. 5) . Thus elevations in intracellular Ca 2ϩ appeared critical to the cross talk response with G s -linked EP receptors.
In additional experiments, we sought to determine whether the activity of PGE 2 could be accounted for by solely by activation of EP 2 and EP 3 receptors. The tissue R and I sc response to PGE 2 (1 m) was compared with that of the EP 2 and EP 3 receptor agonists misoprostol (1 M) or 11-deoxy-16,16-dimethyl-PGE 2 (1 M) (27) . The tissue R and I sc responses to these agonists were similar in magnitude to those of PGE 2 (Fig. 6) . Together, our data indicate that EP 2 and EP 3 receptors were the most likely receptors involved in the response of ischemia-injured porcine ileum to PGE 2 ( Table 2) .
DISCUSSION
In previous studies (3, 4) , we postulated that PGE 2 triggers recovery of R of ischemia-injured porcine ileum by stimulating closure of interepithelial spaces via cAMP. For example, PGE 2 stimulated increases in tissue cAMP, PGE 2 -induced recovery of R was heightened by the phosphodiesterase inhibitor theophylline, and addition of cAMP to ischemic-injured tissues simulated the action of PGE 2 (4, 5) . The present studies confirm an important role for cAMP in PGE 2 -stimulated increases in R but indicate that EP receptor cross talk mechanisms are required to initiate generation of cAMP at prostanoid doses of 1 m. This premise is based on the fact that deoxy-PGE 1 , an agonist that interacts with the G s protein-linked EP 2 and EP 4 receptors, was without effect on R or tissue cAMP levels unless it was applied to ischemia-injured tissue together with an agent that induces increases in intra- (27) . Furthermore, the fact that an EP 2 and EP 3 agonist simulated the action of PGE 2 suggested that, of (23) . For example, in cardiac fibroblasts, muscarinic agonists that signal increases in intracellular Ca 2ϩ via G q protein potentiated elevations in cAMP stimulated by ␤ 2 -agonists, which signal via G s protein (14) . Mechanisms proposed to account for G q and G s protein cross talk included stimulation of Ca 2ϩ / calmodulin sensitive adenylyl cyclase and release of ␤␥-subunits, which act on adenylyl cyclase, by activated G q protein (14) . Although measurements of tissue cAMP in the present study allowed us to define prostanoid interactions required to activate adenylyl cyclase, the precise nature of intracellular Ca 2ϩ signals could not be determined because of the complexity of native mucosa. However, based on experiments with A-23187 and thapsigargin, it appears that increased intracellular Ca 2ϩ (and not activation of G q protein per se) is required to activate adenylyl cyclase. Therefore, there may be other mediators triggered by intracellular Ca 2ϩ that subsequently activate adenylyl cyclase. For example, increased intracellular Ca 2ϩ may activate protein kinase C, which may in turn act on adenylyl cyclase (14) .
One other mechanism that should be considered in the development of cross talk between intracellular Ca 2ϩ and G s protein-mediated agonists is the synergistic effect of Ca 2ϩ and cAMP on intestinal epithelial Cl Ϫ secretion. Such synergism has been attributed to Ca 2ϩ -induced opening of basolateral K ϩ channels, which increases the electromotive driving force for secretion of Cl Ϫ , and cAMP-induced opening of apical Cl Ϫ channels (7, 28) . This may be relevant to the current study, because elevations in R were consistently preceded by elevations in I sc , which we (3) have previously attributed to Cl Ϫ secretion. However, the synergism documented in the present study appears to relate to the necessity for increases in intracellular Ca 2ϩ to induce elevations in cAMP, rather than an interaction between Ca 2ϩ and cAMP. The transient nature of elevations in R in the presence of deoxy-PGE 1 and A-23187 or thapsigargin was somewhat puzzling considering that PGE 2 , which we presume also elevates intracellular Ca 2ϩ via EP 3 receptors, had a more prolonged effect. One possible explanation is that A-23187 and thapsigargin induce only transient elevations in intracellular Ca 2ϩ . Such a transient response to A-23187 has been documented (7) in other intestinal tissues.
Having defined some of the complexities of PGE 2 receptor signaling in ischemia-injured porcine ileum, the clinical relevance of these findings may be considered. In general, we have previously shown (3) that PGE 2 -induced elevations in R result in enhanced recovery of intestinal barrier function, based on mucosalto-serosal fluxes of macromolecules such as mannitol and morphological evidence of "tightening" of interepithelial spaces. Although the current study confirms that a range of prostanoid agonists are capable of triggering increases in R, it appears that agents that selectively interact with EP 2 and EP 3 receptors are capable of reproducing the action of PGE 2 , thereby lessening potential side effects of universal activation of all EP receptors.
